Chen K W, Hughes D C, Klinger H. "Method for the Synthesis of Piperazine Impurity 31" [P]. US Patent, US 10986443 B2, 2016-07-06.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 哌嗪杂质31 in Pharmaceutical Formulations". Phytochemistry, 2021, 1497, 4425-4454.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 哌嗪杂质31 as an Impurity". Chemosphere, 2016, 1683, 4579-4588.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Piperazine Impurity 31 Using HRMS and NMR". J. Sep. Sci., 2015, 1506, (3), 2784-2798.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 哌嗪杂质31 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2014, 311, 5400-5408.